학술논문
A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma
Document Type
Article
Author
Source
In Blood 25 June 2015 125(26):4024-4031
Subject
Language
ISSN
0006-4971